rhein has been researched along with Cardiac Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, G; Li, X; Liao, S; Lu, W; Wu, J; Zhu, H | 1 |
| Belli, B; Fascetti, P; Gentilini, P; La Villa, G; Laffi, G; Marra, F; Meacci, E | 1 |
1 trial(s) available for rhein and Cardiac Failure
| Article | Year |
|---|---|
Effects of rhein on renal arachidonic acid metabolism and renal function in patients with congestive heart failure.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Aged, 80 and over; Aldosterone; Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Cyclooxygenase Inhibitors; Dinoprostone; Double-Blind Method; Female; Heart Failure; Humans; Kidney; Kidney Function Tests; Renin | 1989 |
1 other study(ies) available for rhein and Cardiac Failure
| Article | Year |
|---|---|
Rhein attenuates angiotensin II-induced cardiac remodeling by modulating AMPK-FGF23 signaling.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Anthraquinones; Fibroblast Growth Factor-23; Fibrosis; Heart Failure; Hypertrophy; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Rats; Ventricular Remodeling | 2022 |